Terms: = Head and neck cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Treatment
555 results:
1. The involvement of epidermal growth factor receptor/protein kinase B signaling in the tumor intrinsic PD-L1-induced malignant potential of oral squamous cell carcinoma.
Sasabe E; Tomomura A; Yamamoto T
J Oral Pathol Med; 2024 May; 53(5):310-320. PubMed ID: 38693616
[TBL] [Abstract] [Full Text] [Related]
2. MiR-122-5p regulates erastin-induced ferroptosis via CS in nasopharyngeal carcinoma.
Guo L; Wang Z; Fu Y; Wu S; Zhu Y; Yuan J; Liu Y
Sci Rep; 2024 May; 14(1):10019. PubMed ID: 38693171
[TBL] [Abstract] [Full Text] [Related]
3. Antitumor activity of extracellular signal-regulated kinases 1/2 inhibitor BVD-523 (ulixertinib) on thyroid cancer cells.
Chen Y; Xiao X; Hu G; Liu R; Xue J
J Cancer Res Ther; 2024 Apr; 20(2):570-577. PubMed ID: 38687926
[TBL] [Abstract] [Full Text] [Related]
4. Activation of the MEK/ERK Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, HK2, and GADD45A.
Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
[TBL] [Abstract] [Full Text] [Related]
5. Near-infrared imaging of head and neck squamous cell carcinoma using indocyanine green that targets the
Yuan Y; Fan T; Wang J; Yuan Y; Tao X
J Biomed Opt; 2024 Apr; 29(4):046002. PubMed ID: 38633382
[TBL] [Abstract] [Full Text] [Related]
6. High-Performance Photodynamic Therapy of Tongue Squamous Cell Carcinoma with Multifunctional Nano-Verteporfin.
Yu L; Xu Z; Zhu G; Zeng L; Zhang Z; Yu Y; Wang S; Zhang X; Zhou N; Liang L
Int J Nanomedicine; 2024; 19():2611-2623. PubMed ID: 38505166
[TBL] [Abstract] [Full Text] [Related]
7. m 6 A reader IGF2BP1 reduces the sensitivity of nasopharyngeal carcinoma cells to Taxol by upregulation of AKT2.
Zhao C; Zhang F; Tian Y; Tang B; Luo J; Zhang J
Anticancer Drugs; 2024 Jul; 35(6):501-511. PubMed ID: 38478015
[TBL] [Abstract] [Full Text] [Related]
8. ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β-catenin pathway.
Wang R; Liu X; Li X; Qian M; Yang X; Jiang Q; Wang Y; Liu H; Chen J; Wang X; Gong L
Mol Carcinog; 2024 Jun; 63(6):1079-1091. PubMed ID: 38426809
[TBL] [Abstract] [Full Text] [Related]
9. Anlotinib suppressed tumor cell proliferation and migration in hypopharyngeal carcinoma.
Song H; Song Q; Zhao X; Yang Y; Mou Y; Li Y; Song X
Braz J Otorhinolaryngol; 2024; 90(2):101397. PubMed ID: 38330738
[TBL] [Abstract] [Full Text] [Related]
10. BNIPL is a promising biomarker of laryngeal cancer: novel insights from bioinformatics analysis and experimental validation.
Wang R; Gao Y; Wen S; Guo X
BMC Med Genomics; 2024 Feb; 17(1):45. PubMed ID: 38302910
[TBL] [Abstract] [Full Text] [Related]
11. Resveratrol is an inhibitory polyphenol of epithelial-mesenchymal transition induced by Fusobacterium nucleatum.
Min J; Mashimo C; Nambu T; Maruyama H; Takigawa H; Okinaga T
Arch Oral Biol; 2024 Apr; 160():105897. PubMed ID: 38290225
[TBL] [Abstract] [Full Text] [Related]
12. GLP-1 receptor agonist liraglutide inhibits the proliferation and migration of thyroid cancer cells.
Zhang X; Zhang L; Wang B; Zhang X; Gu L; Guo K; Zhang X; Zhou Z
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):221-225. PubMed ID: 38279433
[TBL] [Abstract] [Full Text] [Related]
13. Exploring the therapeutic potential of curcumin in oral squamous cell carcinoma (HSC-3 cells): Molecular insights into hypoxia-mediated angiogenesis.
Jayaraman S; Veeraraghavan VP; Natarajan SR; Jasmine S
Pathol Res Pract; 2024 Feb; 254():155130. PubMed ID: 38277750
[TBL] [Abstract] [Full Text] [Related]
14. Development and validation of glycosyltransferase related-gene for the diagnosis and prognosis of head and neck squamous cell carcinoma.
He M; Wang L; Yue Z; Feng C; Dai G; Jiang J; Huang H; Ji Q; Zhou M; Li D; Chai W
Aging (Albany NY); 2024 Jan; 16(2):1750-1766. PubMed ID: 38244579
[TBL] [Abstract] [Full Text] [Related]
15. SENP1 inhibits ferroptosis and promotes head and neck squamous cell carcinoma by regulating ACSL4 protein stability via SUMO1.
Xu X; Mao Y; Feng Z; Dai F; Gu T; Zheng J
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186303
[TBL] [Abstract] [Full Text] [Related]
16. TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary Thyroid Carcinoma in a Colombian Cohort.
Cruz-Romero SD; González S; Juez JY; Becerra DS; Baldión AM; Hakim JA; González-Devia D; Perdomo S; Rodríguez-Urrego PA
Adv Ther; 2024 Feb; 41(2):792-805. PubMed ID: 38170436
[TBL] [Abstract] [Full Text] [Related]
17. Factors Affecting Recurrence and Survival for Patients with High-Risk Stage II Melanoma.
Dedeilia A; Lwin T; Li S; Tarantino G; Tunsiricharoengul S; Lawless A; Sharova T; Liu D; Boland GM; Cohen S
Ann Surg Oncol; 2024 Apr; 31(4):2713-2726. PubMed ID: 38158497
[TBL] [Abstract] [Full Text] [Related]
18. Comprehensive molecular findings in primary malignant melanoma of the esophagus: A multicenter study.
Deng L; Wang HY; Hu CF; Liu XY; Jiang K; Yong JJ; Wu XY; Guo KH; Wang F
Pigment Cell Melanoma Res; 2024 May; 37(3):363-371. PubMed ID: 38158377
[TBL] [Abstract] [Full Text] [Related]
19. head and neck squamous cell carcinoma-specific prognostic signature and drug sensitive subtypes based on programmed cell death-related genes.
Xu C; Xu H; Liu B
PeerJ; 2023; 11():e16364. PubMed ID: 38025757
[TBL] [Abstract] [Full Text] [Related]
20. TESC acts as a prognostic factor and promotes epithelial-mesenchymal transition progression in esophageal squamous carcinoma.
Dong Y; Fan B; Li M; Zhang J; Xie S; Di S; Jia Q; Gong T
Pathol Res Pract; 2024 Jan; 253():154964. PubMed ID: 38000203
[TBL] [Abstract] [Full Text] [Related]
[Next]
